{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:45:13Z","timestamp":1792507513050,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.coi.2025.102717","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:06:39Z","timestamp":1767920799000},"page":"102717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Markers predicting lymphoma development in Sj\u00f6gren disease: current status and future perspectives"],"prefix":"10.1016","volume":"99","author":[{"given":"Konstantinos N","family":"Panagiotopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios G","family":"Tzioufas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas V","family":"Goules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102717_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","article-title":"Epidemiology of Sj\u00f6gren syndrome","volume":"20","author":"Beydon","year":"2024","journal-title":"Nat Rev Rheuma"},{"key":"10.1016\/j.coi.2025.102717_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2018.08.007","article-title":"Lymphomagenesis in Sj\u00f6gren\u2019s syndrome: predictive biomarkers towards precision medicine","volume":"18","author":"Goules","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2025.102717_bib3","doi-asserted-by":"crossref","first-page":"50098","DOI":"10.18632\/oncotarget.15100","article-title":"Predictable biomarkers of developing lymphoma in patients with Sj\u00f6gren syndrome: a nationwide population-based cohort study","volume":"8","author":"Chiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.coi.2025.102717_bib4","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/rheumatology\/keab939","article-title":"Clinical picture, outcome and predictive factors of lymphoma in primary Sj\u00f6gren\u2019s syndrome: results from a harmonized dataset (1981\u20132021)","volume":"61","author":"Chatzis","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2025.102717_bib5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","article-title":"Primary Sj\u00f6gren\u2019s syndrome and malignancy risk: a systematic review and meta-analysis","volume":"73","author":"Liang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102717_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9123794","article-title":"Pathogenetic mechanisms implicated in Sj\u00f6gren\u2019s syndrome lymphomagenesis: a review of the literature","volume":"9","author":"Stergiou","year":"2020","journal-title":"JCM"},{"key":"10.1016\/j.coi.2025.102717_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","article-title":"Epithelial\u2013immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis","volume":"17","author":"Verstappen","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102648","article-title":"A biomarker for lymphoma development in Sjogren\u2019s syndrome: salivary gland focus score","volume":"121","author":"Chatzis","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2025.102717_bib9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-204634","article-title":"The prognostic value of routinely performed minor salivary gland assessments in primary Sj\u00f6gren\u2019s syndrome","volume":"73","author":"Risselada","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102717_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2025.102717_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","article-title":"Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren\u2019s syndrome","volume":"44","author":"Ramos-Casals","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2025.102717_sbref12","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1016\/S2665-9913(24)00183-8","article-title":"Identification and evolution of predictors of Sj\u00f6gren\u2019s disease-associated mucosa-associated lymphoid tissue lymphoma development over time: a case-control study","volume":"6","author":"Goules","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_bib13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/rheumatology\/keac470","article-title":"Predicting lymphoma in Sj\u00f6gren\u2019s syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording","volume":"62","author":"De Vita","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2025.102717_bib14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102717_bib15","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1136\/annrheumdis-2017-211290","article-title":"Germinal centres in diagnostic labial gland biopsies of patients with primary Sj\u00f6gren\u2019s syndrome are not predictive for parotid MALT lymphoma development","volume":"76","author":"Haacke","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102717_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2021-221604","article-title":"Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sj\u00f6gren\u2019s syndrome","volume":"81","author":"Broeren","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102717_bib17","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ard.2025.07.021","article-title":"Transcriptomic profiling of Sj\u00f6gren\u2019s disease salivary glands identifies signatures associated with both follicular and extrafollicular responses linked to rheumatoid factor and anti-La\/SSB seropositivity","volume":"84","author":"Pontarini","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102717_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.immuni.2024.12.011","article-title":"A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease","volume":"58","author":"Young","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2025.102717_sbref19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/path.6039","article-title":"Lymphoma-associated mutations in autoreactive memory B cells of patients with Sj\u00f6gren\u2019s syndrome","volume":"259","author":"Bende","year":"2023","journal-title":"J Pathol"},{"key":"10.1016\/j.coi.2025.102717_bib20","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/art.41263","article-title":"Salivary gland mucosa-associated lymphoid tissue-type lymphoma from Sj\u00f6gren\u2019s syndrome patients in the majority express rheumatoid factors affinity-selected for IgG","volume":"72","author":"Bende","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_bib21","doi-asserted-by":"crossref","first-page":"e703","DOI":"10.1016\/S2665-9913(24)00198-X","article-title":"Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sj\u00f6gren\u2019s disease activity: a multicentre, retrospective, observational study","volume":"6","author":"Rocca","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_bib22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/ajh.26715","article-title":"Revised MALT-IPI: a new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma","volume":"97","author":"Alderuccio","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.coi.2025.102717_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.revmed.2023.07.001","article-title":"French national diagnostic and care protocol for Sj\u00f6gren\u2019s disease","volume":"44","author":"Devauchelle-Pensec","year":"2023","journal-title":"La Rev De M\u00e9decine Interne"},{"key":"10.1016\/j.coi.2025.102717_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clim.2017.05.002","article-title":"The value of rituximab treatment in primary Sj\u00f6gren\u2019s syndrome","volume":"182","author":"Verstappen","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2025.102717_bib25","first-page":"2387","article-title":"The impact of two different rituximab-based strategies in cryoglobulinaemic vasculitis secondary to Sj\u00f6gren\u2019s disease: a monocentric cohort study","volume":"42","author":"Longhino","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-025-05935-y","article-title":"High incidence of lymphoma in Sj\u00f6gren\u2019s disease: predictors and mortality implications in a prospective cohort study","volume":"45","author":"Rusinovich-Lovgach","year":"2025","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.coi.2025.102717_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0002-9343(64)90101-9","article-title":"The development of malignant lymphoma in the course of Sj\u00f6gren\u2019s syndrome","volume":"36","author":"Talal","year":"1964","journal-title":"Am J Med"},{"key":"10.1016\/j.coi.2025.102717_bib28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in Sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coi.2025.102717_bib29","first-page":"345","article-title":"Warthin\u2019s tumor with Sj\u00f6gren\u2019s syndrome and non-Hodgkin\u2019s lymphoma","volume":"58","author":"Reiner","year":"1979","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.coi.2025.102717_bib30","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4049\/jimmunol.130.6.2663","article-title":"High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren\u2019s syndrome","volume":"130","author":"Moutsopoulos","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2025.102717_bib31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","article-title":"Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Tzioufas","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2025.102717_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren\u2019s syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2025.102717_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003766","article-title":"Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.coi.2025.102717_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1109\/OJEMB.2020.2965191","article-title":"Predicting lymphoma development by exploiting genetic variants and clinical findings in a machine learning-based methodology with ensemble classifiers in a Cohort of Sj\u00f6gren\u2019s syndrome patients","volume":"1","author":"Kourou","year":"2020","journal-title":"IEEE Open J Eng Med Biol"},{"key":"10.1016\/j.coi.2025.102717_sbref35","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/art.42550","article-title":"Association between Bruton\u2019s tyrosine kinase gene overexpression and risk of lymphoma in primary Sj\u00f6gren\u2019s syndrome","volume":"75","author":"Duret","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_sbref36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1130686","article-title":"Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sj\u00f6gren\u2019s syndrome patients through immunogenetics","volume":"13","author":"Kolijn","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.coi.2025.102717_bib37","article-title":"B-cell receptor signaling is thought to be a bridge between primary Sjogren syndrome and diffuse large B-cell lymphoma","volume":"24","author":"Mohammadnezhad","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.coi.2025.102717_sbref38","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/S2665-9913(23)00340-5","article-title":"Identification of distinct subgroups of Sj\u00f6gren\u2019s disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts","volume":"6","author":"Nguyen","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_sbref39","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/art.43096","article-title":"Distinct pathophysiologic pathways support stratification of Sj\u00f6gren\u2019s disease based on symptoms, clinical, and routine biological data","volume":"77","author":"Nguyen","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_sbref40","first-page":"2507","article-title":"The clinical phenotype of isolated ocular or oral dryness in Sj\u00f6gren\u2019s disease","volume":"42","author":"Chatzis","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_sbref41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105686","article-title":"Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sj\u00f6gren\u2019s syndrome","volume":"91","author":"Benyamine","year":"2024","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.coi.2025.102717_bib42","article-title":"B-cell activation biomarkers in salivary glands are related to lymphomagenesis in primary Sj\u00f6gren\u2019s disease: a pilot monocentric exploratory study","volume":"25","author":"Bruno","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.coi.2025.102717_bib43","article-title":"Exploring risk factors for autoimmune diseases complicated by non-Hodgkin lymphoma through regulatory T cell immune-related traits: a Mendelian randomization study","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102717_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-024-00646-8","article-title":"Transcriptomics explores potential mechanisms for the development of primary Sjogren\u2019s syndrome to diffuse large B-cell lymphoma in B cells","volume":"25","author":"Xu","year":"2024","journal-title":"BMC Immunol"},{"key":"10.1016\/j.coi.2025.102717_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152743","article-title":"Cancer risk in Sj\u00f6gren\u2019s disease: a\u00a0longitudinal cohort study on incidence, predictors, and mortality impact","volume":"73","author":"Rusinovich-Lovgach","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.coi.2025.102717_sbref46","first-page":"43207","article-title":"Deep immunophenotyping and clustering identifies biomarkers predictive of lymphoma in primary Sj\u00f6gren disease","author":"Marques","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_sbref47","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s10067-025-07434-8","article-title":"B lymphocyte subset-based stratification in primary Sj\u00f6gren\u2019s syndrome: implications for lymphoma risk and personalized treatment","volume":"44","author":"Qi","year":"2025","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_bib48","first-page":"2547","article-title":"Impact of gender and age at onset on Sj\u04e7gren\u2019s syndrome presentation and outcome: state of the art","volume":"41","author":"Fulvio","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_bib49","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s10067-024-06993-6","article-title":"The association between primary Sjogren\u2019s syndrome and non-Hodgkin\u2019s lymphoma: a systematic review and meta-analysis of cohort studies","volume":"43","author":"Ansari","year":"2024","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_bib50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/1756-185X.13800","article-title":"Characteristics of diffuse large B-cell lymphoma in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"23","author":"Gorodetskiy","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.coi.2025.102717_bib51","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0961203319857132","article-title":"Prognostic markers of lymphoma development in primary Sj\u00f6gren syndrome","volume":"28","author":"Retamozo","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.coi.2025.102717_bib52","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.autrev.2015.07.002","article-title":"Anti-SSA\/SSB-negative Sj\u00f6gren\u2019s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution","volume":"14","author":"Quartuccio","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2025.102717_bib53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.55563\/clinexprheumatol\/47a4kr","article-title":"Combined seronegativity in Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Chatzis","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-07347-w","article-title":"MTHFR gene variants and non-MALT lymphoma development in primary Sjogren\u2019s syndrome","volume":"7","author":"Fragkioudaki","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2025.102717_bib55","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3899\/jrheum.110754","article-title":"A clinical prediction rule for lymphoma development in primary Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Baldini","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2025.102717_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/rheumatology\/keae152","article-title":"British Society for Rheumatology guideline on management of adult and juvenile onset Sj\u00f6gren disease","volume":"64","author":"Price","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2025.102717_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102717_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103418","article-title":"Evaluation of minor labial salivary gland focus score in Sj\u00f6gren\u2019s disease using deep learning: a tool for more efficient diagnosis and future tissue biomarker discovery","volume":"153","author":"Panagiotopoulos","year":"2025","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2025.102717_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103916","article-title":"Artificial intelligence for biopsies and imaging modalities in systemic autoimmune rheumatic diseases: an instructive narrative review","volume":"24","author":"Panagiotopoulos","year":"2025","journal-title":"Autoimmun Rev"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:35:39Z","timestamp":1784540139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525001931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":59,"alternative-id":["S0952791525001931"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102717","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers predicting lymphoma development in Sj\u00f6gren disease: current status and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102717"}}